Profiling Cellular Morphological Changes Induced by Dual‐Targeting PROTACs of Aurora Kinase and RNA‐Binding Protein YTHDF2

Author:

Goebel Georg L.123,Giannino Nicole12,Lampe Philipp24,Qiu Xiaqiu123,Schloßhauer Jeffrey L.12,Imig Jochen12,Sievers Sonja24,Wu Peng123ORCID

Affiliation:

1. Chemical Genomics Centre Max Planck Institute of Molecular Physiology Otto-Hahn Str. 11 Dortmund 44227 Germany

2. Department of Chemical Biology Max Planck Institute of Molecular Physiology Otto-Hahn Str. 11 Dortmund 44227 Germany

3. Faculty of Chemistry and Chemical Biology TU Dortmund University Otto-Hahn Str. 6 Dortmund 44227 Germany

4. Compound Management and Screening Center Otto-Hahn Str. 15 Dortmund 44227 Germany

Abstract

AbstractProteolysis targeting chimeras (PROTACs) are new chemical modalities that degrade proteins of interest, including established kinase targets and emerging RNA‐binding proteins (RBPs). Whereas diverse sets of biochemical, biophysical and cellular assays are available for the evaluation and optimizations of PROTACs in understanding the involved ubiquitin−proteasome‐mediated degradation mechanism and the structure‐degradation relationship, a phenotypic method profiling the cellular morphological changes is rarely used. In this study, first, we reported the only examples of PROTACs degrading the mRNA‐binding protein YTHDF2 via screening of multikinase PROTACs. Second, we reported the profiling of cellular morphological changes of the dual kinase‐ and RBP‐targeting PROTACs using the unbiased cell painting assay (CPA). The CPA analysis revealed the high biosimilarity with the established aurora kinase cluster and annotated aurora kinase inhibitors, which reflected the association between YTHDF2 and the aurora kinase signaling network. Broadly, the results demonstrated that the cell painting assay can be a straightforward and powerful approach to evaluate PROTACs. Complementary to the existing biochemical, biophysical and cellular assays, CPA provided a new perspective in characterizing PROTACs at the cellular morphology.

Funder

AstraZeneca

Merck KGaA

Max-Planck-Gesellschaft

Volkswagen Foundation

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3